Need a new show to follow? Johnson & Johnson has opened its doors to Lisa Ling, a prominent TV journalist, to create an online series on how the company is working to produce 1 billion doses of a novel coronavirus vaccine.
This week, a series called “The Road to a Vaccine” was launched online featuring insights and interviews with key personnel involved the development of J&J’s lead coronavirus vaccine including Paul Stoffels, the company’s chief scientific officer, Dr. Rinke Bos, a J&J principal scientist. The first episode also features an interview with Dr. Tom Inglesby, the director of John Hopkins University’s Center for Public Health.
J&J is one of several companies in the hunt for an effective coronavirus vaccine. The company plans to put its lead vaccine candidate into human trials starting in September and hopes it can begin producing doses by early next year.
J&J says the new series — which is the first-of-its-kind from a pharma company — will showcase will show how health care workers and public health experts are working collaboratively to “bring an end to the deadly pandemic.”
A new episode of the series will air weekly on jnj.com, Facebook, LinkedIn and Twitter.
Check out the first episode.
